These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 6480801)

  • 1. Mechanism of hyperglycemia and response to treatment with an inhibitor of fatty acid oxidation in a patient with insulin resistance due to antiinsulin receptor antibodies.
    Mandarino L; Tsalikian E; Bartold S; Marsh H; Carney A; Buerklin E; Tutwiler G; Haymond M; Handwerger B; Rizza R
    J Clin Endocrinol Metab; 1984 Oct; 59(4):658-64. PubMed ID: 6480801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the fatty acid oxidation inhibitor methyl palmoxirate (methyl 2-tetradecylglycidate) on recovery from insulin-induced hypoglycemia in diabetic dogs.
    Tuman RW; Bowden CR; Inman M; Altszuler N; Tutwiler GF
    J Pharmacol Exp Ther; 1989 Sep; 250(3):836-41. PubMed ID: 2674419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic control of prevention of nephropathy by 2-tetradecylglycidate in the diabetic mouse (db/db).
    Lee SM; Tutwiler G; Bressler R; Kircher CH
    Diabetes; 1982 Jan; 31(1):12-8. PubMed ID: 6759207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose tolerance and blood pressure are improved in the spontaneously hypertensive rat by ethyl-2-(6-(4-chlorophenoxy)-hexyl)oxirane-2-carboxylate (etomoxir), an inhibitor of fatty acid oxidation.
    Swislocki A; Eason T
    Am J Hypertens; 1994 Aug; 7(8):739-44. PubMed ID: 7986465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous subcutaneous insulin infusion fails to correct impaired basal glucose metabolism and impaired insulin sensitivity of adipocytes from patients with type 1 (insulin-dependent) diabetes.
    Pedersen O; Hjøllund E; Beck-Nielsen H; Richelsen B; Sørensen NS
    Diabetes Res; 1986 Jan; 3(1):17-23. PubMed ID: 3514067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the carnitine palmitoyltransferase inhibitor POCA on myocardial performance and metabolism of insulin resistant rats.
    Rösen P; Reinauer H
    Acta Physiol Hung; 1988; 71(2):271-80. PubMed ID: 3389170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperinsulinemia due to impaired insulin clearance associated with fasting hypoglycemia and postprandial hyperglycemia: an analysis of a patient with antiinsulin receptor antibodies.
    Kiyokawa H; Kono N; Hamaguchi T; Kawachi M; Tajima K; Mineo I; Yamada Y; Shimizu T; Kuwajima M; Tarui S
    J Clin Endocrinol Metab; 1989 Sep; 69(3):616-21. PubMed ID: 2668322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats.
    Tsujihata Y; Ito R; Suzuki M; Harada A; Negoro N; Yasuma T; Momose Y; Takeuchi K
    J Pharmacol Exp Ther; 2011 Oct; 339(1):228-37. PubMed ID: 21752941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of fructose 1,6-bisphosphatase reduces excessive endogenous glucose production and attenuates hyperglycemia in Zucker diabetic fatty rats.
    van Poelje PD; Potter SC; Chandramouli VC; Landau BR; Dang Q; Erion MD
    Diabetes; 2006 Jun; 55(6):1747-54. PubMed ID: 16731838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro effects of antiinsulin receptor antibodies.
    Shimoyama R; Ray TK; Savage CR; Owen OE; Boden G
    J Clin Endocrinol Metab; 1984 Nov; 59(5):916-23. PubMed ID: 6480811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of glucose metabolism by free fatty acid availability in septic and nonseptic rats.
    Lang CH; Dobrescu C
    Circ Shock; 1992 Oct; 38(2):91-102. PubMed ID: 1423926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S26948, a new specific peroxisome proliferator activated receptor gamma modulator improved in vivo hepatic insulin sensitivity in 48 h lipid infused rats.
    Sohn KA; Cruciani-Guglielmacci C; Kassis N; Clément L; Ouali F; Caüzac M; Lebègue N; Berthelot P; Caignard DH; Pégorier JP; Renard P; Dacquet C; Ktorza A; Magnan C;
    Eur J Pharmacol; 2009 Apr; 608(1-3):104-11. PubMed ID: 19250932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site of insulin resistance in type 1 diabetes: insulin-mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro.
    Yki-Järvinen H; Taskinen MR; Kiviluoto T; Hilden H; Helve E; Koivisto VA; Nikkilä EA
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1183-92. PubMed ID: 6490795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different types of postinsulin receptor defects contribute to insulin resistance in hearts of obese Zucker rats.
    Rösen P; Herberg L; Reinauer H
    Endocrinology; 1986 Sep; 119(3):1285-91. PubMed ID: 3732168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative contribution of glycogenolysis and gluconeogenesis to hepatic glucose production in control and diabetic rats. A re-examination in the presence of euglycaemia.
    Giaccari A; Morviducci L; Pastore L; Zorretta D; Sbraccia P; Maroccia E; Buongiorno A; Tamburrano G
    Diabetologia; 1998 Mar; 41(3):307-14. PubMed ID: 9541171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of peripheral insulin levels for insulin-induced suppression of glucose production in depancreatized dogs.
    Giacca A; Fisher SJ; Shi ZQ; Gupta R; Lickley HL; Vranic M
    J Clin Invest; 1992 Nov; 90(5):1769-77. PubMed ID: 1430203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Conditioning of hyperglycemia and hyperinsulinemia in genetically obese mice through resistance to insulin].
    Genes SG
    Fiziol Zh; 1974; 20(2):265-72. PubMed ID: 4595869
    [No Abstract]   [Full Text] [Related]  

  • 18. In vivo metabolic response of glucose to dichloroacetate in humans.
    Brown JA; Gore DC
    J Surg Res; 1996 Mar; 61(2):391-4. PubMed ID: 8656614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes.
    Woerle HJ; Szoke E; Meyer C; Dostou JM; Wittlin SD; Gosmanov NR; Welle SL; Gerich JE
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E67-E77. PubMed ID: 16105859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic profile of methyl 2-tetradecylglycidate (McN-3716)--an orally effective hypoglycemic agent.
    Tutwiler GF; Kirsch T; Mohrbacher RJ; Ho W
    Metabolism; 1978 Oct; 27(10):1539-56. PubMed ID: 692381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.